agilon health, inc. (AGL) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Current obligations | 1.31B USD | Liabilities, Current |
| Cash and equivalents | 107.18M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.31B | $107.18M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.27B | $139.99M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $1.08B | $173.71M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.24B | $171.68M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.25B | $171.42M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.37B | $136.94M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.15B | $188.23M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $1.41B | $148.16M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.39B | $109.49M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.53B | $111.71M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $977.16M | $107.57M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $1.30B | $168.34M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.36B | $190.98M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $972.61M | $394.19M | $422.49M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $535.09M | $497.07M | $411.90M | (m) | (m) | (m) |
| 2022-09-30 | (m) | $658.23M | $551.29M | $407.99M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $605.09M | $668.57M | $285.59M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $610.46M | $1.02B | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $356.96M | $1.04B | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $422.78M | $1.08B | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $412.33M | $1.11B | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $372.11M | $105.29M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $266.83M | $106.80M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |